...
首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Use of a Right Lateral Sector Graft in Living Donor Liver Transplantation Is Feasible, but Special Caution Is Needed With Respect to Liver Anatomy
【24h】

Use of a Right Lateral Sector Graft in Living Donor Liver Transplantation Is Feasible, but Special Caution Is Needed With Respect to Liver Anatomy

机译:在活体供体肝移植中使用右侧外侧移植物是可行的,但在肝解剖方面需要特别注意

获取原文
获取原文并翻译 | 示例

摘要

Right lateral sector (RLS) grafting has been introduced to enlarge the potential donor pool for living donor liver transplantation (LDLT); however, evidence of its feasibility is limited. Data from 437 LDLTs carried out between 2000 and 2013 were analyzed retrospectively. LDLTs using a right liver graft (n = 251) were compared with those using a RLS graft (RLSG; n = 28). No donor mortality occurred, and the major complication rates were similar between the two groups. Postoperative liver function preservation was better in the RLSG donors. Concerning the recipients, the mortality and overall survival rates were similar between the two groups. The complication rate for the recipients was higher when more than two arterial or biliary anastomoses were necessary. A systematic literature search identified four reports on LDLT using RLSGs. Among 66 LDLTs, including the present series, there were no cases of donor death, and the rates of major and minor complications in the donors were 6% and 29%, respectively. The major complication and overall mortality rates in the recipients were 29% and 6%, respectively. LDLT using an RLSG is feasible, with an acceptable survival rate among the recipients.
机译:已经引入了右侧扇形(RLS)移植,以扩大活体供体肝移植(LDLT)的潜在供体库;但是,其可行性的证据有限。回顾性分析了2000年至2013年间进行的437个最不发达国家的数据。将使用右肝移植的LDLT(n = 251)与使用RLS移植的LDLT(RLSG; n = 28)进行了比较。没有发生供者死亡,两组之间的主要并发症发生率相似。 RLSG供者的术后肝功能保存更好。关于接受者,两组的死亡率和总生存率相似。当需要两个以上的动脉或胆道吻合术时,接受者的并发症发生率更高。系统的文献检索使用RLSG确定了关于LDLT的四份报告。在包括本系列在内的66个LDLT中,没有捐献者死亡的案例,捐献者中主要和次要并发症的发生率分别为6%和29%。受者的主要并发症和总死亡率分别为29%和6%。使用RLSG的LDLT是可行的,接受者的生存率可以接受。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号